论文部分内容阅读
在尚不具备玻璃体切割术条件的地区,如何治疗顽固陈旧性玻璃体出血患者,仍是眼科医师关心问题。我院自1985年以来,应用尿激酶半球后注射,治疗玻璃体出血20例26眼,收到满意效果,20例26眼,其中男12例17眼,女8例9眼,年龄23～65岁。疗程为1个月～3年。在临床上均已反复使用过α-糜蛋白酶,安妥碘、复方丹参、脉络宁等中西药治疗,疗效甚微,视力均为光感～手动/眼前一尺,玻璃体内见到陈旧性黑色团块状物,眼底看不清。引起玻璃体出血的原因:眼球挫伤4例4眼,视网膜血管炎2例2眼,静脉周围炎4例6眼,糖尿病性4例8眼,高
In areas where vitrectomy is not yet available, how to treat patients with stubborn obsolete vitreous hemorrhage remains a concern for ophthalmologists. Our hospital since 1985, the application of urokinase hemisphere after injection, treatment of 20 cases of vitreous hemorrhage 26, received satisfactory results, 20 cases 26 eyes, including 12 males and 17 females, 8 females and 9 eyes, aged 23 to 65 years . Treatment for 1 month ~ 3 years. In the clinical use of a-chymotrypsin, diazepam, compound salvia miltiorrhiza, Mailuoning other Chinese and Western medicine treatment, with little efficacy, visual acuity are light ~ manual / immediate anterior vitreous to see the old black group Block, the fundus can not see clearly. Causes of vitreous hemorrhage: 4 cases of eyeball contusion in 4 cases, 2 cases of retinal vasculitis in 2 cases, 4 cases of venous inflammation in 6 cases, 4 cases of diabetic 8 eyes, high